Joshua Adam Barocas, MD

Adjunct Assistant Professor, Medicine

Joshua Barocas
314.348.3278
jbarocas@bu.edu
View full profile at BUMC

Biography

I lead an interdisciplinary research program that is specifically aimed at the goal of improving health outcomes for patients with infectious diseases including HIV and HCV, substance use disorders, and other vulnerable populations. My research, which uses clinical epidemiology, health economics, simulation modeling, and cost-effectiveness, informs clinical-decision making and health policy to answer clinically- and policy-relevant questions. I am engaged in research using these innovative methods to help understand the impact of and improve upon policies that affect people who use drugs infected with or at high risk for infections. My research is currently been funded by NIDA in the form of both a K01 and a DP2 award as well as multiple grants for which I am a Co-Investigator. I have also received NIAID, the Providence/Boston Center for AIDS Research (CFAR), the BU-CTSI, and the MGH Executive Committee on Research Fund for Medical Discovery. I currently serve as Director of the Health Economics and Modeling Core for the Massachusetts HEALing Communities Study, an NIH-funded grant to significantly reduce overdose. I am the previous recipient of the Charles A. King Trust Research Award, and the prestigious AAMC Herbert W. Nickens Faculty Fellowship Award, which recognizes a junior faculty member who demonstrates leadership potential in addressing inequity in health care. I have published my work and editorials in leading journals such as NEJM, Lancet Public Health, JAMA Internal Medicine, AJPH, Addiction, Clinical Infectious Diseases, and Annals of Internal Medicine. My work has been widely cited in the media, including the Boston Globe, U.S. News and World Report, and NPR.

Websites

Education

  • George Washington University School of Medicine, MD
  • Washington University in St. Louis, BA

Publications

  • Published on 9/28/2023

    Tin Y, Castry M, Bowers-Sword R, Shantharam S, Aldridge A, Zarkin GA, Starbird L, Linas BP, Barocas JA, Morgan JR. Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths. J Addict Med. 2023 Sep 28. PMID: 37768777.

    Read at: PubMed
  • Published on 9/26/2023

    Wang J, Doogan N, Thompson K, Bernson D, Feaster D, Villani J, Chandler R, White LF, Kline D, Barocas JA. Massachusetts Prevalence of Opioid Use Disorder Estimation Revisited: Comparing a Bayesian Approach to Standard Capture-Recapture Methods. Epidemiology. 2023 Nov 01; 34(6):841-849. PMID: 37757873.

    Read at: PubMed
  • Published on 9/18/2023

    Savinkina A, Jurecka C, Gonsalves G, Barocas JA. Mortality, incarceration and cost implications of fentanyl felonization laws: A modeling study. Int J Drug Policy. 2023 Sep 18; 121:104175. PMID: 37729682.

    Read at: PubMed
  • Published on 9/5/2023

    Flam-Ross JM, Marsh E, Weitz M, Savinkina A, Schackman BR, Wang J, Madushani RWMA, Morgan JR, Barocas JA, Walley AY, Chrysanthopoulou SA, Linas BP, Assoumou SA. Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder. JAMA Netw Open. 2023 Sep 05; 6(9):e2329583. PMID: 37703018.

    Read at: PubMed
  • Published on 6/28/2023

    Palis H, Barocas JA, Moe J, Scow M, Sedgemore KO, Slaunwhite AK, Buxton JA. Rising rates of infective endocarditis in North America: An urgent need for attention to the rapidly changing unregulated drug supply. Int J Drug Policy. 2023 Aug; 118:104110. PMID: 37390695.

    Read at: PubMed
  • Published on 5/2/2023

    Barocas JA, Nall SK, Axelrath S, Pladsen C, Boyer A, Kral AH, Meehan AA, Savinkina A, Peery D, Bien M, Agnew-Brune C, Goldshear J, Chiang J, Linas BP, Gonsalves G, Bluthenthal RN, Mosites E. Population-Level Health Effects of Involuntary Displacement of People Experiencing Unsheltered Homelessness Who Inject Drugs in US Cities. JAMA. 2023 May 02; 329(17):1478-1486. PMID: 37036716.

    Read at: PubMed
  • Published on 4/3/2023

    Jawa R, Tin Y, Nall S, Calcaterra SL, Savinkina A, Marks LR, Kimmel SD, Linas BP, Barocas JA. Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Netw Open. 2023 Apr 03; 6(4):e237888. PMID: 37043198.

    Read at: PubMed
  • Published on 1/6/2023

    Jurecka CA, Barocas JA. Using Evidence to Inform Legislation Aimed at Curbing Fentanyl Deaths. JAMA Health Forum. 2023 Jan 06; 4(1):e225202. PMID: 36705915.

    Read at: PubMed
  • Published on 11/22/2022

    Thompson K, Barocas JA, Delcher C, Bae J, Hammerslag L, Wang J, Chandler R, Villani J, Walsh S, Talbert J. The prevalence of opioid use disorder in Kentucky's counties: A two-year multi-sample capture-recapture analysis. Drug Alcohol Depend. 2023 Jan 01; 242:109710. PMID: 36469995.

    Read at: PubMed
  • Published on 11/19/2022

    Doogan NJ, Mack A, Wang J, Crane D, Jackson R, Applegate M, Villani J, Chandler R, Barocas JA. Opioid Use Disorder Among Ohio's Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method. Am J Epidemiol. 2022 Nov 19; 191(12):2098-2108. PMID: 36004683.

    Read at: PubMed

View 79 more publications: View full profile at BUMC

View all profiles